In this study, ChIP-seq and dual-luciferase reporter assay revealed that BRG1-mediated inhibition of PPP2R1A was necessary for its regulatory effects on AKT phosphorylation in B-ALL. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.